beta

TLC

Taiwan Liposome Co., Ltd.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Taiwan Liposome Co., Ltd. engages in the authorized cooperative development of special medicine as well as new formulation and prescription drugs. The firm offers pain management, ophthalmology, and oncology related drugs based on lipid drug delivery system. It also provides royalties and biotechnology services. The company was founded by Chi Lung Hung on November 10, 1997 and is headquartered in Taipei, Taiwan.

Market Cap: 136 Million

Primary Exchange: NASDAQ

Website: http://www.tlcbio.com

Shares Outstanding: 37 Million

Float:

Dividend: (%)

Beta: 0.199435151960731

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 321 trading days

From: 2019-01-07 To: 2020-04-07

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud